US Based MedAx Capital connects biotech and life science executives with Wall Street dealmakers during “Medicine’s Golden Age”

 Breaking News
  • No posts were found

US Based MedAx Capital connects biotech and life science executives with Wall Street dealmakers during “Medicine’s Golden Age”

October 04
21:04 2021
US Based MedAx Capital connects biotech and life science executives with Wall Street dealmakers during "Medicine's Golden Age"
MedAx Capital is an international investment firm that focuses solely on emerging Biotech, Life Science and Healthcare companies. The team at Medax Capital offers customized investment advice and offers investors access to high profile private companies before they go public.

NEW YORK, NY, USA – In the last few years, the life sciences market has grown tremendously as M&A and investment deals have outpaced activity in almost all other industries in both volume and market cap. Notwithstanding the economic and geopolitical environment that has affected virtually all industries in 2020, companies in HealthTech and MedTech space seem more resilient than ever. Experts believe that regardless of any potential slowdown in 2021, the fundamental strength of the life sciences sector will continue to promote dealmaking activity, continuing its outperformance. MedAx Capital, a boutique investment firm based in New York, is well positioned to play a significant role in this space by connecting high potential, innovative ideas and ventures with Wall Street dealmakers.

According to a report by EY, many of 2020’s deal drivers in life sciences remain in play in 2021. That suggests 2022 will be an active year for deals in this sector, at least in terms of overall volume. Focused growth remains a catchphrase for C-suites and boards alike. And despite 2020’s market volatility, life science companies ended the year with record levels of dealmaking.

MedAx Capital, founded by Sean Michael Murphy, is the culmination of over 25 years of honed skills and strategic relationships in the life sciences and healthcare arenas. The company started off as a group of clients comprised of doctors and surgeons, but over the years, it has transformed into a comprehensive network of scientists, geneticists, and bioengineers.

“Big Pharma is spending more money than ever before on R&D to discover innovative and novel breakthroughs. This has created an environment rife with opportunities,” says Mr. Murphy.

Mr. Murphy has been working in the finance industry for over 25 years. He has a keen eye to uncover disruptive business models in biotech and life science. He has worked extensively with corporate clients, specifically, promising life science companies that discover, develop, and commercialize innovative products.

MedAx Capital offers specialized financial advisory services that includes Investment Banking, Private Equity, Options/Hedging, Portfolio Management. The company has designed comprehensive workflows and effective investment strategies. As part of their investment advisory services, they offer access to high profile private companies like 23 & Me, SoFi, BitPay, and Triller before they go public.

The experienced team at MedAx Capital realizes that when it comes to crafting investment strategies for their clients, a “One Size Fits All” strategy simply doesn’t work. They tailor their approach to meet the needs of each of their clients. As a result, you can view their website for a growing list of satisfied clients sharing their individual experiences working with MedAx.

“I have been working with Sean and he is very easy to get a hold of and always there for me. I always feel I have a friend and advisor that is protecting my interests in everything,” said Dr. Jaafar from NYC.

“I met Sean many years ago and agreed to give him a shot. To his credit I am still a client. Sean is always available, which is helpful since I now live in Thailand, but most of the time he is the one calling me to give updates. Service second to none,” said T. Grimm from Thailand.

“We strongly believe that our unique skill set, deep knowledge and expertise in the industry, connections with Wall Street executives, and key opinion leaders create a unique opportunity to deliver value for our clients,” says Mr. Murphy. “We understand this niche inside out. Our team has the experience and expertise to craft customized investment strategies based on our client’s specific requirements, risk tolerance, liquidity needs, and time horizon.”

About MedAx Capital

MedAx Capital works with some of the world’s most respected key opinion leaders and published researchers in the life sciences and healthcare fields. By bridging the divide between these successful leaders and institutional quality investments, MedAx Capital makes it possible to “Monetize Medicine”.

For more information about MedAx Capital and other inquiries, send an email at [email protected] or reach out via the website (

Media Contact
Company Name: MedAx Capital
Contact Person: Sean Michael Murphy
Email: Send Email
Phone: 212.548.6203
City: New York
State: NY
Country: United States

Related Articles